Pediatric HIV Infection Clinical Trial
Official title:
Evaluating an HIV Risk Screening Tool for Use in a Population of Orphans and Other Vulnerable Children in Tanzania
The goal of the research was to evaluate the performance of items within the Kizazi Kipya (K2) Orphan and Vulnerable Children (OVC) HIV risk screening tool in identifying HIV-positive children, to optimize an HIV screening tool for OVC and children and adolescents in facility settings and to assess the feasibility and acceptability of home-based HIV risk screening and testing.
Under the ongoing community-based Kizazi Kipya (K2) OVC project, program staff currently
administer a 13-item HIV risk screening tool to all K2 program beneficiaries, and refers
those who screen positive to facility-based HIV testing. A subset of this 13-item tool is a
module of four items that had previously been used as a standalone four-question screening
tool in facilities in Zimbabwe.
The primary objectives of this study are as follows.
1. To evaluate the performance of a lay cadre-administered four-item subset of the K2 HIV
risk screening tool that matches the Zimbabwe evidence-based tool in predicting the HIV
status of vulnerable children/adolescents represented by two populations: (a) K2 OVC
beneficiaries and (b) children/adolescents attending health facilities.
2. To identify additional items in the K2 HIV risk screening tool that could be added to
the four-question subset to improve the tool's performance.
3. To assess fidelity to the administration of the OVC HIV screening tool items through
structured observations of community case workers in the K2 program.
4. To assess the acceptability of OVC HIV risk screening and testing implemented in the
community among OVC beneficiaries in the K2 program.
5. To assess the acceptability and feasibility of integrating the OVC HIV screening tool
with HIV testing among OVC community case workers in the K2 program.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06281834 -
Dolutegravir Pharmacokinetics During Weekly Rifapentine/Isoniazid for TB Prevention
|
Phase 1 | |
Completed |
NCT04206878 -
Evaluating the Feasibility of Point of Care Birth Testing in Eswatini
|
||
Recruiting |
NCT05069688 -
Dolutegravir Pharmacokinetics Among HIV/TB Coinfected Children Receiving Standard and High-dose Rifampicin
|
Phase 1 | |
Active, not recruiting |
NCT03024762 -
Active Search for Pediatric HIV/AIDS (ASPA)
|
N/A | |
Recruiting |
NCT05006170 -
Pharmacokinetics, Safety, and Efficacy of Dolutegravir Dispersible Tablets in Young Children Living With HIV
|
Phase 2 | |
Not yet recruiting |
NCT03980119 -
Utilizing the HITSystem for Optimizing Paediatric ART Retention and Adherence in Western Nyanza Province, Kenya
|
N/A | |
Completed |
NCT03824067 -
Impact of Point-of-Care EID for HIV-Exposed Infants
|
N/A |